Hence, the elucidation of a novel EGFR/EpCAM cross talk in HNSCCs additionally defined pERK1/2 and Slug as biomarkers for the stratification of HNSCC patients. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.